Smeralda, W.; Since, M.; Corvaisier, S.; Fayolle, D.; Cardin, J.; Duprey, S.; Jourdan, J.-P.; Cullin, C.; Malzert-Freon, A.
A Biomimetic Multiparametric Assay to Characterise Anti-Amyloid Drugs. Int. J. Mol. Sci. 2023, 24, 16982.
https://doi.org/10.3390/ijms242316982
AMA Style
Smeralda W, Since M, Corvaisier S, Fayolle D, Cardin J, Duprey S, Jourdan J-P, Cullin C, Malzert-Freon A.
A Biomimetic Multiparametric Assay to Characterise Anti-Amyloid Drugs. International Journal of Molecular Sciences. 2023; 24(23):16982.
https://doi.org/10.3390/ijms242316982
Chicago/Turabian Style
Smeralda, Willy, Marc Since, Sophie Corvaisier, Dimitri Fayolle, Julien Cardin, Sylvain Duprey, Jean-Pierre Jourdan, Christophe Cullin, and Aurélie Malzert-Freon.
2023. "A Biomimetic Multiparametric Assay to Characterise Anti-Amyloid Drugs" International Journal of Molecular Sciences 24, no. 23: 16982.
https://doi.org/10.3390/ijms242316982
APA Style
Smeralda, W., Since, M., Corvaisier, S., Fayolle, D., Cardin, J., Duprey, S., Jourdan, J.-P., Cullin, C., & Malzert-Freon, A.
(2023). A Biomimetic Multiparametric Assay to Characterise Anti-Amyloid Drugs. International Journal of Molecular Sciences, 24(23), 16982.
https://doi.org/10.3390/ijms242316982